Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II venetoclax plus decitabine as a bridge to allogeneic stem cell transplantation in older adults with newly diagnosed acute myeloid leukemia
2020-002297-26Phase 2Active
- Sponsor
- GITMO
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of venetoclax and decitabine in acute myeloid leukemia (AML), sponsored by GITMO. Started Jan 2021; status: active.
02
Drugs
venetoclaxdecitabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on 2020-002297-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002297-26.